Flaxseed Oil

NutraPedia - Evidence-Based Supplement Research

Back to Table of Contents
Health Goals: heart inflammation skin

Research Overview

Across the reviewed studies, flaxseed oil research is most heavily concentrated in (i) compositional and mechanistic work linking its high α-linolenic acid (ALA, an omega‑3 PUFA) content and associated phytochemicals to biological effects, and (ii) broad, multi-endpoint narrative reviews covering cardiometabolic, inflammatory, antioxidant, and disease-related outcomes (e.g., cardiovascular disease risk factors, diabetes-related markers, cancer-related pathways, neuroprotection). A second prominent area is food and feed technology aimed at overcoming flaxseed oil’s key limitation—oxidative instability—using formulation strategies (e.g., liposomal encapsulation with biopolymer coatings) and antioxidant systems, as well as applications in animal nutrition to improve dietary n‑6:n‑3 fatty acid balance using plant-based omega‑3 sources as alternatives to fish oil.

The strongest and most consistent support in these studies is for flaxseed oil as a rich dietary source of ALA and as a candidate ingredient for improving fatty-acid profiles in foods and feeds, with plausible cardiometabolic and anti-inflammatory relevance. Evidence is also comparatively strong that oxidation is a central practical constraint and that stabilization approaches can meaningfully improve shelf-life and digestion-release behavior in model systems (e.g., coated liposomes showing improved oxidative stability and slower in vitro release). Antioxidant studies further support that efficacy depends on antioxidant chemistry and interfacial behavior rather than polarity alone, and that some commonly presumed antioxidants (e.g., α‑tocopherol in the cited study) may be ineffective or even pro-oxidant under certain conditions—highlighting the need for formulation-specific validation.

Key gaps are the translation of mechanistic and preclinical findings into consistent human clinical outcomes and clearer dose–response relationships for flaxseed oil specifically (as distinct from whole or ground flaxseed, which also provide lignans and fiber and may have different bioavailability profiles). The studies also point to a broader issue in functional-food research: human trials on inflammatory and metabolic mediators remain inconclusive, suggesting a need for larger, well-controlled randomized trials with standardized oil preparations, oxidation-state monitoring, and clinically meaningful endpoints. Additional research is warranted on long-term safety and real-world effectiveness across populations, comparative effectiveness versus other PUFA-rich oils, and how processing/encapsulation strategies influence bioavailability, efficacy, and product acceptability.

1. What conditions has Flaxseed Oil been studied for?

  • Cardiometabolic risk factors and chronic disease prevention: Reviews describe flaxseed oil (rich in ALA) as being studied in relation to cardiovascular disease, atherosclerosis, diabetes/metabolic outcomes, and broader chronic disease risk.

  • Inflammation-related conditions: A systematic review of clinical trials on “functional foods” includes flaxseed oil among foods studied for effects on inflammatory and metabolic mediators; a separate meta-analysis evaluated flaxseed/flax derivatives on C-reactive protein (CRP).

  • Gastrointestinal/intestinal barrier injury (preclinical): In weaned pigs, flaxseed oil was studied for protection against LPS-induced intestinal injury and barrier dysfunction (e.g., morphology, claudin-1, inflammatory signaling pathways).

  • Cancer, arthritis, osteoporosis, autoimmune and neurological disorders (mostly review-level claims): Multiple reviews list these as areas of investigation for flaxseed oil and/or flaxseed components, though the studies reviewed here do not detail specific human trial outcomes for these conditions.

  • Food technology/oxidation stability (not a medical condition): Multiple studies examined flaxseed oil oxidation and stabilization strategies (antioxidants, nanoemulsions, liposome coatings), which is relevant to product quality and safety rather than disease treatment.

  • Companion animal inflammation management (dietary ratio focus): A review discusses plant ALA oils (including flaxseed oil) as alternatives to fish oil to influence the dietary n-6:n-3 ratio and inflammatory response in dogs/cats/horses.

2. Does it work in treating those conditions? Summarize the evidence.

  • Inflammation (CRP) in humans: mixed/mostly null overall. A meta-analysis of randomized controlled trials of flaxseed and its derivatives (including flaxseed oil) found no overall reduction in CRP (p = 0.428). However, heterogeneity was substantial, and baseline BMI modified response: among participants with BMI ≥ a threshold (abstract indicates an effect in higher BMI), CRP decreased by 0.83 mg/L (95% CI −1.34 to −0.31; p = 0.002).

  • Intestinal injury/barrier function (animal evidence): supportive. In weaned pigs, dietary flaxseed oil (5% vs corn oil) enriched intestinal ALA/EPA/total n-3, improved intestinal morphology, increased jejunal lactase activity and claudin-1, and downregulated mRNA markers in TLR4/MyD88/NF-κB and NOD1/2-RIPK2 pathways and necroptotic signals after LPS challenge. This supports a protective effect in that model, but it is not direct evidence of clinical efficacy in humans.

  • Cardiometabolic disease treatment in humans: not established from these studies. The provided reviews state potential benefits across cardiovascular disease, diabetes, and metabolic outcomes, but the studies here do not provide specific human trial effect sizes for flaxseed oil itself. One flaxseed-focused abstract (not oil-specific) states regular flaxseed consumption may improve lipid profile and blood pressure and reduce fasting glucose/HOMA-IR, but it also notes bioavailability depends on form and that ground flaxseed is preferred for bioactive availability—so these findings cannot be assumed to apply to flaxseed oil alone.

  • Cancer/arthritis/osteoporosis/neurological disorders: insufficient clinical evidence in these studies. These are listed as studied areas in reviews, but no clinical trial outcomes are presented in the studies reviewed here to conclude treatment efficacy.

3. What health benefits does it have?

  • Provides ALA (omega-3): Flaxseed oil is highlighted as rich in α-linolenic acid (ALA), a precursor to long-chain omega-3s (EPA/DHA). In the pig study, flaxseed oil increased intestinal ALA and EPA and total n-3 PUFA levels.

  • Potential anti-inflammatory effects (context-dependent): Reviews attribute anti-inflammatory properties to flaxseed/flaxseed oil. Human CRP evidence is overall null, but a subgroup with higher BMI showed a statistically significant CRP reduction in the meta-analysis.

  • Potential cardiometabolic support (mainly review-level in these studies): Reviews describe cardioprotective and metabolic effects and potential roles in cardiovascular disease/atherosclerosis/diabetes risk reduction, though the studies reviewed here do not quantify flaxseed oil’s clinical impact.

  • Gut barrier support (preclinical): In LPS-challenged pigs, flaxseed oil improved markers of intestinal integrity (morphology, claudin-1) and downregulated inflammatory signaling pathways.

  • Sustainability/alternative to fish oil (dietary strategy): In companion animal nutrition, plant ALA oils (including flaxseed oil) are presented as more environmentally sustainable options than fish oil for improving dietary n-6:n-3 balance, with possible benefits beyond serving as an EPA/DHA precursor.

4. Does it have any downsides or side effects?

  • Oxidation/rancidity risk (product quality and potentially tolerability): Flaxseed oil is described as highly susceptible to oxidative deterioration. One study found several natural antioxidants delayed oxidation, but alpha-tocopherol showed a pro-oxidant effect at all tested concentrations in that system, and natural antioxidants were less effective than TBHQ on a mass basis. Oxidation can affect taste/odor and may generate undesirable oxidation products, making storage/formulation important.

  • Form-dependent loss of non-oil components: Flaxseed oil lacks much of the fiber and most lignans found in whole/ground flaxseed; one abstract emphasizes that ground flaxseed is preferred to ensure high bioavailability of certain bioactives (especially lignans). This is a “downside” if someone expects whole-seed benefits from oil alone.

  • Antinutrients noted for flaxseed (not specifically oil): An abstract lists cyanogenic glycosides, cadmium, trypsin inhibitors, and phytic acid as flaxseed antinutrients. These are primarily relevant to seed/meal rather than refined oil, and the studies reviewed here do not report adverse events from flaxseed oil in humans.

  • Clinical side effects not characterized here: The studies reviewed here do not detail human adverse-event rates (e.g., GI upset, bleeding risk, interactions), so no evidence-based conclusion about common side effects can be drawn from these texts alone.

5. Is it beneficial or harmful for any genetic variations (pharmacogenomics)?

The studies reviewed here do not report pharmacogenomic analyses or genotype-stratified outcomes for flaxseed oil (e.g., variants affecting ALA-to-EPA/DHA conversion or inflammatory response). Therefore, based on these studies alone:

  • No specific genetic variants can be identified as making flaxseed oil clearly beneficial or harmful.

  • Any discussion of genotype effects (for example, variants in fatty-acid desaturase pathways) would be speculative without direct evidence from the cited studies.

References

  1. Flax and flaxseed oil: an ancient medicine & modern functional food.
    Ankit Goyal, Vivek Sharma, Neelam Upadhyay, Sandeep Gill, Manvesh Sihag (2014) - Journal of food science and technology
  2. A comprehensive review of the health benefits of flaxseed oil in relation to its chemical composition and comparison with other omega-3-rich oils.
    Somaia Al-Madhagy, Naglaa S Ashmawy, Ayat Mamdouh, Omayma A Eldahshan, Mohamed A Farag (2023) - European journal of medical research
  3. The Chemical Composition and Health-Promoting Benefits of Vegetable Oils-A Review.
    Mingke Tian, Yuchen Bai, Hongyu Tian, Xuebing Zhao (2023) - Molecules (Basel, Switzerland)
  4. The Role of Flaxseed in Improving Human Health.
    Wioletta Nowak, Małgorzata Jeziorek (2023) - Healthcare (Basel, Switzerland)
  5. Preparation, characterization, and evaluation of flaxseed oil liposomes coated with chitosan and pea protein isolate hydrolysates.
    Fanfan Song, Jie Chen, Zhengquan Zhang, Shaojun Tian (2023) - Food chemistry
  6. The balance of n-6 and n-3 fatty acids in canine, feline, and equine nutrition: exploring sources and the significance of alpha-linolenic acid.
    Scarlett Burron, Taylor Richards, Giovane Krebs, Luciano Trevizan, Alexandra Rankovic, Samantha Hartwig, Wendy Pearson, David W L Ma, Anna K Shoveller (2024) - Journal of animal science
  7. Oxidative stability of flaxseed oil: Effect of hydrophilic, hydrophobic and intermediate polarity antioxidants.
    Athira Mohanan, Michael T Nickerson, Supratim Ghosh (2018) - Food chemistry
  8. Performance and antioxidant traits of broiler chickens fed with diets containing rapeseed or flaxseed oil and optimized quercetin.
    Kamil Sierżant, Eliza Piksa, Damian Konkol, Kamila Lewandowska, Muhammad Umair Asghar (2023) - Scientific reports
  9. Functional foods modulating inflammation and metabolism in chronic diseases: a systematic review.
    Julissa Luvián-Morales, Francisco Omar Varela-Castillo, Laura Flores-Cisneros, Lucely Cetina-Pérez, Denisse Castro-Eguiluz (2022) - Critical reviews in food science and nutrition
  10. Effect of flaxseed polyphenols on physical stability and oxidative stability of flaxseed oil-in-water nanoemulsions.
    Chen Cheng, Xiao Yu, David Julian McClements, Qingde Huang, Hu Tang, Kun Yu, Xia Xiang, Peng Chen, Xintian Wang, Qianchun Deng (2019) - Food chemistry
  11. Flaxseed Oil Attenuates Intestinal Damage and Inflammation by Regulating Necroptosis and TLR4/NOD Signaling Pathways Following Lipopolysaccharide Challenge in a Piglet Model.
    Huiling Zhu, Haibo Wang, Shuhui Wang, Zhixiao Tu, Lin Zhang, Xiuying Wang, Yongqing Hou, Chunwei Wang, Jie Chen, Yulan Liu (2018) - Molecular nutrition & food research
  12. Chitosan Coating Functionalized with Flaxseed Oil and Green Tea Extract as a Bio-Based Solution for Beef Preservation.
    Cíntia G Mendes, Joana T Martins, Fernanda L Lüdtke, Ana Geraldo, Alfredo Pereira, António A Vicente, Jorge M Vieira (2023) - Foods (Basel, Switzerland)
  13. Effect of Flaxseed Intervention on Inflammatory Marker C-Reactive Protein: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Guan-Yu Ren, Chun-Yang Chen, Guo-Chong Chen, Wei-Guo Chen, An Pan, Chen-Wei Pan, Yong-Hong Zhang, Li-Qiang Qin, Li-Hua Chen (2016) - Nutrients
  14. The effect of flaxseed oil consumtion on blood pressure among patients with metabolic syndrome and related disorders: A systematic review and meta-analysis of randomized clinical trials.
    Trias Mahmudiono, Saade Abdalkareem Jasim, Yasir Salam Karim, Dmitry Olegovich Bokov, Walid Kamal Abdelbasset, Kholmurod S Akhmedov, Ghulam Yasin, Lakshmi Thangavelu, Yasser Fakri Mustafa, Shehla Shoukat, Mazin A A Najm, Mohammad Amraei (2022) - Phytotherapy research : PTR
  15. Phospholipidomics and quantum chemistry calculation unravel the changes in phospholipid molecules of flaxseed oil during roasting.
    Dong Zhang, Xiaoliang Duan, Hui Sun (2023) - Food chemistry
  16. Effect of Ferulic Acid and Its Derivatives on Cold-Pressed Flaxseed Oil Oxidative Stability and Bioactive Compounds Retention during Oxidation.
    Natalia Mikołajczak, Wojciech Pilarski, Krzysztof Gęsiński, Małgorzata Tańska (2023) - Foods (Basel, Switzerland)
  17. Linseed Essential Oil - Source of Lipids as Active Ingredients for Pharmaceuticals and Nutraceuticals.
    Joana R Campos, Patricia Severino, Classius S Ferreira, Aleksandra Zielinska, Antonello Santini, Selma B Souto, Eliana B Souto (2019) - Current medicinal chemistry
  18. Flaxseed Oil Alleviates PFOS-Induced Liver Injury by Regulating Hepatic Cholesterol Metabolism.
    Jingyi Ren, Jinshi Zuo, Bowen Yin, Dan Huang, Rui Wen, Huanting Pei, Jiarui Liu, Yadong Zhang, Siqi Zhu, Shuman Zhen, Yuxia Ma (2024) - Journal of agricultural and food chemistry
  19. Effect of Flaxseed Oil Cake Extract on the Microbial Quality, Texture and Shelf Life of Gluten-Free Bread.
    Łukasz Łopusiewicz, Przemysław Łukasz Kowalczewski, Hanna Maria Baranowska, Łukasz Masewicz, Ryszard Amarowicz, Urszula Krupa-Kozak (2023) - Foods (Basel, Switzerland)


Related

This article summarizes published research for educational purposes. It is not medical advice. Talk to your doctor before starting, stopping, or changing any supplement or medication.

Want personalized supplement recommendations based on your genetics?
Upload Whole Genome Sequencing (WGS) raw DNA data today!
Or upload raw DNA data to get started with your free analysis!